JP2008508354A5 - - Google Patents

Download PDF

Info

Publication number
JP2008508354A5
JP2008508354A5 JP2007524780A JP2007524780A JP2008508354A5 JP 2008508354 A5 JP2008508354 A5 JP 2008508354A5 JP 2007524780 A JP2007524780 A JP 2007524780A JP 2007524780 A JP2007524780 A JP 2007524780A JP 2008508354 A5 JP2008508354 A5 JP 2008508354A5
Authority
JP
Japan
Prior art keywords
boswellic acid
keto
acetyl
composition according
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007524780A
Other languages
English (en)
Japanese (ja)
Other versions
JP4820819B2 (ja
JP2008508354A (ja
Filing date
Publication date
Priority claimed from US10/710,778 external-priority patent/US7582314B2/en
Application filed filed Critical
Priority claimed from PCT/US2004/033846 external-priority patent/WO2006022762A1/en
Publication of JP2008508354A publication Critical patent/JP2008508354A/ja
Publication of JP2008508354A5 publication Critical patent/JP2008508354A5/ja
Application granted granted Critical
Publication of JP4820819B2 publication Critical patent/JP4820819B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007524780A 2004-08-02 2004-10-14 過剰増殖性皮膚疾患を治療するための組成物および方法 Expired - Fee Related JP4820819B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/710,778 US7582314B2 (en) 2003-12-03 2004-08-02 Compositions and methods for the management of hyperproliferative dermatological conditions
US10/710,778 2004-08-02
PCT/US2004/033846 WO2006022762A1 (en) 2004-08-02 2004-10-14 Compositions and methods for the management of hyperproliferative dermatological conditions

Publications (3)

Publication Number Publication Date
JP2008508354A JP2008508354A (ja) 2008-03-21
JP2008508354A5 true JP2008508354A5 (enExample) 2008-05-08
JP4820819B2 JP4820819B2 (ja) 2011-11-24

Family

ID=35967805

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007524780A Expired - Fee Related JP4820819B2 (ja) 2004-08-02 2004-10-14 過剰増殖性皮膚疾患を治療するための組成物および方法

Country Status (12)

Country Link
EP (1) EP1791423B1 (enExample)
JP (1) JP4820819B2 (enExample)
CN (1) CN101132693B (enExample)
AU (1) AU2004322710B2 (enExample)
DK (1) DK1791423T3 (enExample)
ES (1) ES2422893T3 (enExample)
NZ (1) NZ552027A (enExample)
PL (1) PL1791423T3 (enExample)
PT (1) PT1791423E (enExample)
RU (1) RU2366412C2 (enExample)
WO (1) WO2006022762A1 (enExample)
ZA (1) ZA200700694B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0913499B1 (pt) * 2008-09-15 2020-03-17 Laila Nutraceuticals Composições anti-inflamatórias sinergísticas compreendendo extratos de boswellia serrata
ITVR20080125A1 (it) * 2008-11-13 2010-05-14 Phytonature Sas Di Masini Dr Antoni O E C Nuova forma di preparazione ed utilizzo della boswellia serrata
WO2011099029A1 (en) * 2010-02-15 2011-08-18 Laila Nutraceuticals A novel boswellia low polar gum resin extract and its synergistic compositions
US20110218172A1 (en) * 2010-03-02 2011-09-08 Muhammed Majeed Composition for down-regulating pro-inflammatory markers
CN102670565A (zh) * 2011-03-14 2012-09-19 苏州博创园生物医药科技有限公司 一种含天然药物的透皮吸收贴片
CN102670690A (zh) * 2011-03-14 2012-09-19 苏州博创园生物医药科技有限公司 一种抗牛皮癣纯天然药物乳膏及其制备方法
CN103193853A (zh) * 2012-01-06 2013-07-10 苏州博创园生物医药科技有限公司 用于治疗银屑病的化合物、组合物及其制备方法
US9498423B2 (en) * 2012-05-07 2016-11-22 Sami Labs Limited Synergistic selenopeptide formulations for the protection of dermal papilla cells
US20200179305A1 (en) * 2016-04-19 2020-06-11 Azura Ophthalmics Ltd. Compositions for the Treatment of Hyperkeratosis Disorders
US9975917B1 (en) 2017-09-20 2018-05-22 King Saud University Pentacyclic triterpenoidal derivatives
CN115279458A (zh) 2020-01-10 2022-11-01 阿祖拉眼科有限公司 组合物和敏感性说明
EP4295842A1 (en) 2022-06-24 2023-12-27 Faaborg Pharma - IP ApS A skin care composition

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3670084A (en) * 1969-06-20 1972-06-13 Leopoldo F Montes Method of treating psoriasis with cycloheximide
DE4201903B4 (de) * 1992-01-24 2004-04-15 Hermann P.T. Prof. Dr.Med. Ammon Pharmazeutische Verwendung von Boswelliasäuren
DE4445728A1 (de) * 1994-12-21 1996-06-27 Simmet Th Prof Dr Verwendung von Boswelliasäure zur Behandlung von Hirntumoren
US5536506A (en) * 1995-02-24 1996-07-16 Sabinsa Corporation Use of piperine to increase the bioavailability of nutritional compounds
RU2152218C1 (ru) * 1998-04-21 2000-07-10 Дальневосточный государственный медицинский университет Способ лечения псориаза
CN1064264C (zh) * 1998-04-28 2001-04-11 山东省滨州卫生学校 富硒灵芝在制备治疗银屑病的药物中的应用
US6399105B1 (en) * 1999-01-20 2002-06-04 Peter Donald Collin Sea cucumber carotenoid lipid fraction products and methods of use
WO2000066111A1 (en) * 1999-04-30 2000-11-09 Sabinsa Corporation Compositions of boswellic acids derived from boswellia serrata gum resin, for treating lymphoproliferative and autoimmune conditions
CA2451267A1 (en) * 2002-12-13 2004-06-13 Warner-Lambert Company Llc Pharmaceutical uses for alpha2delta ligands
GB0230203D0 (en) * 2002-12-27 2003-02-05 Domantis Ltd Fc fusion
ATE449081T1 (de) * 2002-12-30 2009-12-15 Celgene Corp Fluoralkoxy-substituierte 1, 3-dihydro-isoindolyl-verbindungen und ihre pharmazeutischen verwendungen

Similar Documents

Publication Publication Date Title
Priya et al. Healing potential of Datura alba on burn wounds in albino rats
Castaldo et al. Propolis, an old remedy used in modern medicine
LS Propolis in dentistry and oral cancer management
JP2008508354A5 (enExample)
KR20100016450A (ko) 피부 외용제 조성물
CA2716874A1 (en) A pharmaceutical composition and its use in the preparation of a medicament for the treatment of cerebrovascular diseases
JP2015512386A5 (enExample)
JP2011513437A5 (enExample)
US20230270807A1 (en) Antimicrobial compositions
Carata et al. Powerful properties of ozonated extra virgin olive oil
ATE340561T1 (de) Verwendung von antiseptika zur herstellung von arzneimitteln zur prophylaxe und behandlung von entzündungen im korperinneren des menschen
JPWO2021099781A5 (enExample)
WO2011104900A1 (ja) 抗真菌剤
JP2018528259A5 (enExample)
Grover et al. Curcumin: A medicinal plant and its effects in medicine and dentistry
AR048806A1 (es) Uso de cariofilenos en la elaboracion de medicamentos y tratamiento de afecciones corporales de inflamacion y dolor inflamatorio
Dickinson et al. Rolling Stone
ATE454139T1 (de) Arzneimittel mit shikonin als wirkstoff
JP6422737B2 (ja) ロキソプロフェンを配合する外用剤組成物
ES2377612A1 (es) Uso de crassula para el tratamiento de enfermedades proliferativas.
Isadkar et al. Aloe vera as denture cleanser
CN101837068B (zh) 椒目仁油喷雾剂的制备工艺和应用
Torres et al. DETOXSAN paste formulation containing zeolites for the treatment of mycosis and intertrigo carried out under climatic conditions of Cuba
Ali et al. Euphorbia pulcherrima leaves facilitated preparation of silver/silver chloride nanoparticles with antioxidant and in vivo anticancer potentials against Ehrlich ascites carcinoma
WO2015027669A3 (zh) 苯基取代化合物及其药物组合物和应用